Journal
BLOOD
Volume 98, Issue 2, Pages 428-435Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.V98.2.428
Keywords
-
Categories
Funding
- PHS HHS [P0-1 78378] Funding Source: Medline
Ask authors/readers for more resources
Multiple myeloma (MM) remains incurable, with a median survival of 3 to 4 years. This study shows direct effects of vascular endothelial growth factor (VEGF) upon NIM and plasma cell leukemia (PCL) cells. The results indicate that VEGF triggers tumor cell proliferation via a protein kinase C (PKC)-independent Raf-1-MEK-extracellular signal-regulated protein kinase pathway and migration via a PKC-dependent pathway. These observations provide the framework for novel therapeutic strategies targeting VEGF signaling cascades in MM. (C) 2001 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available